Lipoprotein Lipase Antikörper
(2 Referenzen)-
- Target Alle Lipoprotein Lipase (LPL) Antikörper anzeigen
- Lipoprotein Lipase (LPL)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Lipoprotein Lipase Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- LPL Antibody
- Aufreinigung
- Ascitic fluid
- Immunogen
- Purified recombinant fragment of LPL expressed in E. Coli.
- Klon
- 2C5
- Isotyp
- IgG1
- Top Product
- Discover our top product LPL Primärantikörper
-
anti-Lipoprotein Lipase (LPL) (AA 28-474) antibody
LPL Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoprotein Lipase (LPL) (AA 300-327) antibodyLPL Reaktivität: Human WB, IHC, ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoprotein Lipase (LPL) (AA 55-316) antibodyLPL Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoprotein Lipase (LPL) antibodyLPL Reaktivität: Human WB, ICC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoprotein Lipase (LPL) (AA 162-246) antibodyLPL Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoprotein Lipase (LPL) (AA 1-475) antibodyLPL Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoprotein Lipase (LPL) antibodyLPL Reaktivität: Human, Ratte, Maus, Syrischer Goldhamster, Cat WB, ELISA, FACS, IF, InhA Wirt: Maus Monoclonal 5D2 unconjugated
anti-Lipoprotein Lipase (LPL) (AA 300-327) antibodyLPL Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoprotein Lipase (LPL) antibodyLPL Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoprotein Lipase (LPL) (AA 401-475) antibodyLPL Reaktivität: Human, Ratte, Maus WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- ELISA: 1/10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
: "Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides." in: Human mutation, Vol. 30, Issue 1, pp. 49-55, (2009) (PubMed).
: "Higher post-absorptive skeletal muscle LPL activity in African American vs. non-Hispanic White pre-menopausal women." in: Obesity (Silver Spring, Md.), Vol. 16, Issue 1, pp. 199-201, (2008) (PubMed).
-
: "Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides." in: Human mutation, Vol. 30, Issue 1, pp. 49-55, (2009) (PubMed).
-
- Target
- Lipoprotein Lipase (LPL)
- Andere Bezeichnung
- LPL (LPL Produkte)
- Synonyme
- HDLCQ11 antikoerper, LIPD antikoerper, fb62e04 antikoerper, fc49b03 antikoerper, wu:fb62e04 antikoerper, wu:fc49b03 antikoerper, LPL antikoerper, lipd antikoerper, hdlcq11 antikoerper, lpl antikoerper, LOC100223817 antikoerper, lipoprotein lipase antikoerper, LPL antikoerper, Lpl antikoerper, lpl antikoerper
- Hintergrund
-
Description: LPL: lipoprotein lipase, also known as LIPD, HDLCQ11. Entrez Protein: NP_000228. It is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
Aliases: LIPD, HDLCQ11
- Molekulargewicht
- 53.1kDa
- Gen-ID
- 4023
- HGNC
- 4023
- UniProt
- P06858
- Pathways
- Lipid Metabolism
-
